Company / Debt per Share
Harmony Biosciences Holdings, Inc. Debt per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Debt per Share
$2.86
FY2025
5-year range
$2.86 / $3.34
FY2021-FY2025
Trend
-9.3%
vs FY2024
Sector context
#37 of 82
Health Care
What the data says
At $2.86, Harmony Biosciences Holdings, Inc.'s debt per share ranks #46 of 82 in the Health Care sector. Debt per Share has declined for 5 consecutive years, from $24.94 in FY2020 to $2.86 in FY2025.
Based on SEC 10-K filings.
2.86 in FY2025 with a 5-year CAGR of -35.1%.
Improved from $3.25 to $2.86 over the past 2 years.
Health Care sector context is included.
Debt per Share over time
Growth rates
- 3-Year CAGR
- -4.2%
- 5-Year CAGR
- -35.1%
- 10-Year CAGR
- -
Sector benchmark
#46 of 82 in Health CareTop 55% of 82This company $2.86 Sector average $126.59
▼
-97.7% below sector average
Key checks
Key Insights
- Harmony Biosciences Holdings, Inc.'s debt per share has declined for 5 consecutive years.
- In FY2025, debt per share decreased 9.3% year-over-year.
- Ranks #37 out of 82 companies in the Health Care sector.
- Peak debt per share was recorded in FY2020.
Company context
Key Data Points
- Strong profit margin: 20.4%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.86 | -9.3% |
| FY2024 | $3.16 | -2.7% |
| FY2023 | $3.25 | -0.3% |
| FY2022 | $3.26 | -2.4% |
| FY2021 | $3.34 | -86.6% |
| FY2020 | $24.94 | +98.1% |
| FY2019 | $12.59 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026